Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tryp Therapeutics Inc (TRYP.CN)

Tryp Therapeutics Inc (TRYP.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade TRYP.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.600 +11.67%
on 04/14/21
0.880 -23.86%
on 03/15/21
-0.210 (-23.86%)
since 03/12/21
3-Month
0.500 +34.00%
on 01/27/21
1.200 -44.17%
on 02/17/21
+0.070 (+11.67%)
since 01/14/21

Most Recent Stories

More News
Mainstream Mental Health is Quickly Embracing Psychedelic Drug Therapies

These days, we can make a very strong case for mind-altering treatments for mental health. Not ...

SEEL : 4.82 (-2.23%)
CLXPF : 1.4600 (-1.35%)
MMEDF : 2.4300 (-3.57%)
TRYP.CN : 0.670 (+1.52%)
SILO.CN : 0.230 (+2.22%)
Tryp Therapeutics Announces Listing on OTCQB and DTC Eligibility

San Diego, California--(Newsfile Corp. - April 5, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("" or the "") a pharmaceutical company focused on developing clinical-stage compounds for diseases...

OTCM : 40.0000 (-2.44%)
TRYP.CN : 0.670 (+1.52%)
TRYPF : 0.4865 (-7.61%)
Tryp Therapeutics Announces Amendment to Option Plan and Option Grant

San Diego, California--(Newsfile Corp. - April 1, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) ("" or the ""), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet...

TRYP.CN : 0.670 (+1.52%)
Tryp Therapeutics Appoints Greg McKee as Chief Executive Officer

San Diego, California--(Newsfile Corp. - April 1, 2021) -  Tryp Therapeutics Inc. (CSE: TRYP) ("" or the ""), a pharmaceutical company focused on developing clinical-stage compounds for diseases with...

TRYPF : 0.4865 (-7.61%)
TRYP.CN : 0.670 (+1.52%)
Psilocybin May be Able to Help Nearly a Third of the U.S. Adults Considered Obese

Psychedelics, like psilocybin may be helpful in treating weight issues and obesity. In fact, NeonMind ...

CLXPF : 1.4600 (-1.35%)
MMEDF : 2.4300 (-3.57%)
CMPS : 35.95 (-1.15%)
NMDBF : 0.1800 (unch)
TRYP.CN : 0.670 (+1.52%)
NEON.CN : 0.220 (-2.22%)
More People Are Turning to Psychedelics to Treat Mental Health Issues

Psychedelic treatments could revolutionize the way millions are treated for mental health issues. So ...

PSYCF : 0.2009 (-3.13%)
MSSTF : 0.3984 (-13.39%)
MYCOF : 0.2671 (+1.40%)
NUMI.VN : 0.950 (-1.04%)
LKYSF : 0.7584 (+1.11%)
TRYP.CN : 0.670 (+1.52%)
MSET.CN : 0.490 (-10.91%)
MYCO.CN : 0.350 (+7.69%)
PSYC.CN : 0.250 (unch)
Tryp Therapeutics Announces Provisional Patent Filing For Improved Administration of Psychedelics

La Jolla, California--(Newsfile Corp. - March 18, 2021) -  Tryp Therapeutics (CSE: TRYP), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs,...

TRYPF : 0.4865 (-7.61%)
TRYP.CN : 0.670 (+1.52%)
Psilocybin Therapy Could Help With Obesity

The world is in desperate need for new treatments for major issues, such as mental health and obesity. ...

CLXPF : 1.4600 (-1.35%)
TRYP.CN : 0.670 (+1.52%)
MMEDF : 2.4300 (-3.57%)
CMPS : 35.95 (-1.15%)
NMDBF : 0.1800 (unch)
NEON.CN : 0.220 (-2.22%)
Tryp Therapeutics Appoints Luke Hayes as Chief Financial Officer

La Jolla, California--(Newsfile Corp. - March 9, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) ("" or the ""), a pharmaceutical company focused on identifying and developing clinical-stage compounds for diseases...

DOW : 64.24 (+1.47%)
TRYPF : 0.4865 (-7.61%)
TRYP.CN : 0.670 (+1.52%)
Tryp Therapeutics Announces Application to List on OTCQB

La Jolla, California--(Newsfile Corp. - March 4, 2021) - Tryp Therapeutics (CSE: TRYP) ("Tryp" or the "Company") a pharmaceutical company focused on identifying and developing clinical-stage compounds...

OTCM : 40.0000 (-2.44%)
TRYPF : 0.4865 (-7.61%)
TRYP.CN : 0.670 (+1.52%)

Key Turning Points

3rd Resistance Point 0.763
2nd Resistance Point 0.717
1st Resistance Point 0.693
Last Price 0.670
1st Support Level 0.623
2nd Support Level 0.577
3rd Support Level 0.553

See More

52-Week High 1.200
Fibonacci 61.8% 0.933
Fibonacci 50% 0.850
Fibonacci 38.2% 0.767
Last Price 0.670
52-Week Low 0.500

See More

Business Summary

Tryp Therapeutics Inc is a pharmaceutical company focused on identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs. The company's main development program PFN program, is designed to treat neuropsychiatric disorders through the dosing...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar